A leading techno-commercial company has developed a digital authentication technology for the pharmaceutical industry in order to address the increasing threat of counterfeit products. According to the company, an acute shortage of drugs to treat the symptoms of COVID-19 has led to more counterfeit drugs circulating lately. It added that there are reports of fake antiviral drugs and fake immunosuppressive injectables that exist in the marketplace. Given the increasing demand for vaccines, there is concern that fake vaccines may end up in circulation.
Earlier this year, the World Health Organization warned regarding the criminal exploitation of unsatisfied global demand for COVID-19 vaccines. Counterfeit vaccines have already been identified in several countries. A digital code has been incorporated into the drug product packaging, so that the end-user can validate the product's…
